ImmunityBio (IBRX) stock: insider trades, news & valuation
Heavy sellingShare price and insider trades
ImmunityBio insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 3 sold $9.5M of IBRX stock on the open market.
Get emailed when insiders cluster-buy stocks like IBRX
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
IBRX insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | $1.1M | 2 |
| Q3 2026 | — | 0 | $2.7M | 2 |
| Q2 2026 | — | 0 | $1.2M | 4 |
| Q1 2026 | — | 0 | $4.5M | 8 |
Valuation, profit and volume
Summary
Over the past 12 months, 0 ImmunityBio, Inc. insiders reported open-market purchases totaling $0, while 3 insiders reported sales totaling $9.5M. 16 of 16 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Oct 6SEC | Cheryl CohenDirector | Sell Plan | 81,056100,309 held (−45%) | $10.50 | $851K | +0.1% | — |
| Oct 6SEC | Barry J. SimonDirector | Sell Plan | 25,0002,777,788 held (−1%) | $10.75 | $269K | -2.2% | — |
| Jul 6SEC | Christobel SeleckyDirector | Sell Plan | 159,478 | $9.02 | $1.4M | +16.5% | — |
| Jul 6SEC | Cheryl CohenDirector | Sell Plan | 131,210125,386 held (−51%) | $9.50 | $1.2M | +10.6% | — |
| Jul 1SEC | Christobel SeleckyDirector | Sell Plan | 95,722 | $9.01 | $862K | +16.6% | — |
| Jul 1SEC | Christobel SeleckyDirector | Sell Plan | 1,000 | $9.00 | $9K | +16.8% | — |
| Jun 26SEC | Barry J. SimonDirector | Sell Plan | 25,0002,802,788 held (−1%) | $7.88 | $197K | +33.4% | — |
| Jun 5SEC | Barry J. SimonDirector | Sell Plan | 23,0332,827,788 held (−1%) | $7.18 | $165K | +46.4% | — |
| Feb 26SEC | Barry J. SimonDirector | Sell Plan | 75,0002,850,821 held (−3%) | $12.01 | $901K | -12.5% | — |
| Feb 24SEC | Barry J. SimonDirector | Sell Plan | 165,0002,925,821 held (−5%) | $10.25 | $1.7M | +2.5% | — |
| Feb 24SEC | Christobel SeleckyDirector | Sell Plan | 25,000 | $10.00 | $250K | +5.1% | — |
| Feb 24SEC | Barry J. SimonDirector | Sell Plan | 10,0003,081,604 held (−0%) | $9.25 | $92K | +13.6% | — |
| Jan 21SEC | Barry J. SimonDirector | Sell Plan | 75,0003,091,604 held (−2%) | $7.88 | $591K | +33.4% | — |
| Jan 21SEC | Barry J. SimonDirector | Sell Plan | 76,9673,166,604 held (−2%) | $6.54 | $503K | +60.7% | — |
| Jan 21SEC | Christobel SeleckyDirector | Sell Plan | 50,000 | $5.00 | $250K | +110.2% | — |
| Jan 21SEC | Christobel SeleckyDirector | Sell Plan | 25,000 | $7.51 | $188K | +39.9% | — |
Insiders at ImmunityBio, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Barry J. SimonDirector | — | $4.4M | Oct 6, 2026 | — |
| Christobel SeleckyDirector | — | $3.0M | Jul 6, 2026 | — |
| Cheryl CohenDirector | — | $2.1M | Oct 6, 2026 | — |
IBRX stock: common questions
Are ImmunityBio, Inc. insiders buying IBRX stock?
In the past 12 months, 0 insiders reported open-market purchases of IBRX worth $0.
Are ImmunityBio, Inc. insiders selling IBRX stock?
3 insiders reported sales worth $9.5M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is IBRX's 52-week range?
Over the past year IBRX has traded between $1.98 and $11.55. It last closed at $10.51 on Oct 9, 2026.